Snowball logo
logo
UR9

Clinuvel Pharmaceuticals Limited

UR9 MU
5.760.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025
Revenue
Total revenue
47.9865.7278.3288.1895.02
COGS
4.72030510.488.78952110.0815.88
Gross Profit
43.2655.2469.5378.179.14
Operating Expenses & Income
Operating Income
28.2235.3344.148.0145.73
Total Operating Expenses
-----
R&D Expenses
-----
Selling General & Admin Expenses
12.7617.7122.5725.0326.85
Earnings from Continuing Operations
Interest Expense
(1.61843)(2.274357)(3.192713)(4.454292)(4.462838)
Interest Income
0.3422030.4440713.9058567.3248719.430521
Income Tax Expense
-----
Net Income
Net Income
24.7320.8830.635.6436.17
Supplemental
EBIT
-----
EBITDA
28.1937.3549.56--
In millions of EUR, except % and values per 1 share